18.07.23|Sophie ShulmanThe Israeli company’s main product is a metered-dose inhaler for pain reduction treatment using medical cannabis
07.05.19|Orna YefetPerry Davidson, founder and CEO of cannabis inhaler company Syqe Medical, spoke Monday at Calcalist's cannabis conference in Tel Aviv
01.01.19|Amarelle WenkertSyqe develops a pocket-sized metered-dose inhaler designed for precise delivery of cannabis molecules
29.07.18|KPMG, a CTech partnerTransforming cannabis into precisely-dosed treatment has made it medically and financially legitimacy, says Perry Davidson, the founder of Syqe Medical, which developed a precise cannabis inhaler
14.01.18|Keren Hagai and Joseph I. WyseWhile U.S. regulators hamper cannabis-related research, Israeli cannabis startups draw the attention of investors and collaborators